25H-NBOMe

25H-NBOMe
Clinical data
Other names	2C-H-NBOMe; NBOMe-2C-H; DMPEA-NBOMe; N-(2-Methoxybenzyl)-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-N-(2-methoxybenzyl)phenethylamine
Drug class	Serotonin 5-HT receptor agonist; Serotonergic psychedelic; Hallucinogen
ATC code	None;
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); DE: NpSG (Industrial and scientific use only); UK: Class A;
Identifiers
	IUPAC name 2-(2,5-Dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine;
CAS Number	919797-16-3 ;
PubChem CID	39424372;
ChemSpider	25511924 ;
UNII	RN5ZVN74Y9;
Chemical and physical data
Formula	C18H23NO3
Molar mass	301.386 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COC1=CC(=C(C=C1)OC)CCNCC2=CC=CC=C2OC;
	InChI InChI=1S/C18H23NO3/c1-20-16-8-9-18(22-3)14(12-16)10-11-19-13-15-6-4-5-7-17(15)21-2/h4-9,12,19H,10-11,13H2,1-3H3; Key:RMLXCDMTGWSEOU-UHFFFAOYSA-N;

25H-NBOMe, also known as NBOMe-2C-H, is a derivative of the phenethylamine hallucinogen 2C-H, which acts as a highly potent full agonist for the human 5-HT_2A receptor.